ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global MRI-Safe Neurostimulation System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-19O17222
Home | Market Reports | Health| Health Conditions
Global MRI Safe Neurostimulation System Market Research Report 2024
BUY CHAPTERS

Global MRI-Safe Neurostimulation System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-19O17222
Report
November 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
AADCO Medical Inc.
Boston Scientific
Sorin
St.Jude Medical
Biotronik AG
Nevro Corporation
Boston Scientific Corporation
Cyberonics, lnc.
Codman & Shurtleff's
Codman & Shurtleff's

MRI-Safe Neurostimulation System Market

The global MRI-Safe Neurostimulation System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
deliver neurostimulation therapy to patients while ensuring compatibility with magnetic resonance imaging (MRI) procedures. MRI machines use powerful magnets and radio waves to generate detailed images of the body's internal structures, making them invaluable in diagnosing and monitoring various medical conditions.
From a downstream perspective, Hospitals & Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
MRI-Safe Neurostimulation System leading manufacturers including Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global MRI-Safe Neurostimulation System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of MRI-Safe Neurostimulation System Market Report

Report Metric Details
Report Name MRI-Safe Neurostimulation System Market
Segment by Type
  • Implantable
  • Transcutaneous
Segment by Application
  • Hospitals & Clinics
  • Diagnostic Labs and Centers
  • Ambulatory Surgical Centers
  • Research Laboratories
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the MRI-Safe Neurostimulation System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the MRI-Safe Neurostimulation System Market report?

Ans: The main players in the MRI-Safe Neurostimulation System Market are Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation

What are the Application segmentation covered in the MRI-Safe Neurostimulation System Market report?

Ans: The Applications covered in the MRI-Safe Neurostimulation System Market report are Hospitals & Clinics, Diagnostic Labs and Centers, Ambulatory Surgical Centers, Research Laboratories

What are the Type segmentation covered in the MRI-Safe Neurostimulation System Market report?

Ans: The Types covered in the MRI-Safe Neurostimulation System Market report are Implantable, Transcutaneous

1 Study Coverage
1.1 Introduction to MRI-Safe Neurostimulation System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global MRI-Safe Neurostimulation System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Implantable
1.2.3 Transcutaneous
1.3 Market Segmentation by Application
1.3.1 Global MRI-Safe Neurostimulation System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Labs and Centers
1.3.4 Ambulatory Surgical Centers
1.3.5 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global MRI-Safe Neurostimulation System Revenue Estimates and Forecasts 2020-2031
2.2 Global MRI-Safe Neurostimulation System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global MRI-Safe Neurostimulation System Sales Estimates and Forecasts 2020-2031
2.4 Global MRI-Safe Neurostimulation System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global MRI-Safe Neurostimulation System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global MRI-Safe Neurostimulation System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Implantable Market Size by Manufacturers
3.5.2 Transcutaneous Market Size by Manufacturers
3.6 Global MRI-Safe Neurostimulation System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global MRI-Safe Neurostimulation System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global MRI-Safe Neurostimulation System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global MRI-Safe Neurostimulation System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global MRI-Safe Neurostimulation System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America MRI-Safe Neurostimulation System Sales and Revenue by Type (2020-2031)
6.4 North America MRI-Safe Neurostimulation System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America MRI-Safe Neurostimulation System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe MRI-Safe Neurostimulation System Sales and Revenue by Type (2020-2031)
7.4 Europe MRI-Safe Neurostimulation System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe MRI-Safe Neurostimulation System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific MRI-Safe Neurostimulation System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific MRI-Safe Neurostimulation System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific MRI-Safe Neurostimulation System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America MRI-Safe Neurostimulation System Sales and Revenue by Type (2020-2031)
9.4 Central and South America MRI-Safe Neurostimulation System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America MRI-Safe Neurostimulation System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa MRI-Safe Neurostimulation System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa MRI-Safe Neurostimulation System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa MRI-Safe Neurostimulation System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic Inc.
11.1.1 Medtronic Inc. Corporation Information
11.1.2 Medtronic Inc. Business Overview
11.1.3 Medtronic Inc. MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.1.4 Medtronic Inc. MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Inc. MRI-Safe Neurostimulation System Sales by Product in 2024
11.1.6 Medtronic Inc. MRI-Safe Neurostimulation System Sales by Application in 2024
11.1.7 Medtronic Inc. MRI-Safe Neurostimulation System Sales by Geographic Area in 2024
11.1.8 Medtronic Inc. MRI-Safe Neurostimulation System SWOT Analysis
11.1.9 Medtronic Inc. Recent Developments
11.2 Cyberonics, lnc.
11.2.1 Cyberonics, lnc. Corporation Information
11.2.2 Cyberonics, lnc. Business Overview
11.2.3 Cyberonics, lnc. MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.2.4 Cyberonics, lnc. MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cyberonics, lnc. MRI-Safe Neurostimulation System Sales by Product in 2024
11.2.6 Cyberonics, lnc. MRI-Safe Neurostimulation System Sales by Application in 2024
11.2.7 Cyberonics, lnc. MRI-Safe Neurostimulation System Sales by Geographic Area in 2024
11.2.8 Cyberonics, lnc. MRI-Safe Neurostimulation System SWOT Analysis
11.2.9 Cyberonics, lnc. Recent Developments
11.3 AADCO Medical Inc.
11.3.1 AADCO Medical Inc. Corporation Information
11.3.2 AADCO Medical Inc. Business Overview
11.3.3 AADCO Medical Inc. MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.3.4 AADCO Medical Inc. MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 AADCO Medical Inc. MRI-Safe Neurostimulation System Sales by Product in 2024
11.3.6 AADCO Medical Inc. MRI-Safe Neurostimulation System Sales by Application in 2024
11.3.7 AADCO Medical Inc. MRI-Safe Neurostimulation System Sales by Geographic Area in 2024
11.3.8 AADCO Medical Inc. MRI-Safe Neurostimulation System SWOT Analysis
11.3.9 AADCO Medical Inc. Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.4.4 Boston Scientific MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Boston Scientific MRI-Safe Neurostimulation System Sales by Product in 2024
11.4.6 Boston Scientific MRI-Safe Neurostimulation System Sales by Application in 2024
11.4.7 Boston Scientific MRI-Safe Neurostimulation System Sales by Geographic Area in 2024
11.4.8 Boston Scientific MRI-Safe Neurostimulation System SWOT Analysis
11.4.9 Boston Scientific Recent Developments
11.5 Sorin
11.5.1 Sorin Corporation Information
11.5.2 Sorin Business Overview
11.5.3 Sorin MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.5.4 Sorin MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sorin MRI-Safe Neurostimulation System Sales by Product in 2024
11.5.6 Sorin MRI-Safe Neurostimulation System Sales by Application in 2024
11.5.7 Sorin MRI-Safe Neurostimulation System Sales by Geographic Area in 2024
11.5.8 Sorin MRI-Safe Neurostimulation System SWOT Analysis
11.5.9 Sorin Recent Developments
11.6 St. Jude Medical
11.6.1 St. Jude Medical Corporation Information
11.6.2 St. Jude Medical Business Overview
11.6.3 St. Jude Medical MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.6.4 St. Jude Medical MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 St. Jude Medical Recent Developments
11.7 Biotronik
11.7.1 Biotronik Corporation Information
11.7.2 Biotronik Business Overview
11.7.3 Biotronik MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.7.4 Biotronik MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Biotronik Recent Developments
11.8 Codman & Shurtleff's
11.8.1 Codman & Shurtleff's Corporation Information
11.8.2 Codman & Shurtleff's Business Overview
11.8.3 Codman & Shurtleff's MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.8.4 Codman & Shurtleff's MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Codman & Shurtleff's Recent Developments
11.9 Nevro Corporation
11.9.1 Nevro Corporation Corporation Information
11.9.2 Nevro Corporation Business Overview
11.9.3 Nevro Corporation MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.9.4 Nevro Corporation MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Nevro Corporation Recent Developments
11.10 Boston Scientific Corporation
11.10.1 Boston Scientific Corporation Corporation Information
11.10.2 Boston Scientific Corporation Business Overview
11.10.3 Boston Scientific Corporation MRI-Safe Neurostimulation System Product Models, Descriptions and Specifications
11.10.4 Boston Scientific Corporation MRI-Safe Neurostimulation System Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Boston Scientific Corporation Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 MRI-Safe Neurostimulation System Industry Chain
12.2 MRI-Safe Neurostimulation System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 MRI-Safe Neurostimulation System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 MRI-Safe Neurostimulation System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 MRI-Safe Neurostimulation System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global MRI-Safe Neurostimulation System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Medtronic Inc
AADCO Medical Inc.
Boston Scientific
Sorin
St.Jude Medical
Biotronik AG
Nevro Corporation
Boston Scientific Corporation
Cyberonics, lnc.
Codman & Shurtleff's
Codman & Shurtleff's
List of Tables
 Table 1. Global MRI-Safe Neurostimulation System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global MRI-Safe Neurostimulation System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global MRI-Safe Neurostimulation System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global MRI-Safe Neurostimulation System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global MRI-Safe Neurostimulation System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global MRI-Safe Neurostimulation System Sales by Region (2020-2025) & (K Units)
 Table 8. Global MRI-Safe Neurostimulation System Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global MRI-Safe Neurostimulation System Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global MRI-Safe Neurostimulation System Sales Share by Manufacturers (2020-2025)
 Table 12. Global MRI-Safe Neurostimulation System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global MRI-Safe Neurostimulation System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global MRI-Safe Neurostimulation System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRI-Safe Neurostimulation System as of 2024)
 Table 16. Global MRI-Safe Neurostimulation System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global MRI-Safe Neurostimulation System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers MRI-Safe Neurostimulation System Manufacturing Base and Headquarters
 Table 19. Global MRI-Safe Neurostimulation System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global MRI-Safe Neurostimulation System Sales by Type (2020-2025) & (K Units)
 Table 23. Global MRI-Safe Neurostimulation System Sales by Type (2026-2031) & (K Units)
 Table 24. Global MRI-Safe Neurostimulation System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global MRI-Safe Neurostimulation System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global MRI-Safe Neurostimulation System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global MRI-Safe Neurostimulation System Sales by Application (2020-2025) & (K Units)
 Table 29. Global MRI-Safe Neurostimulation System Sales by Application (2026-2031) & (K Units)
 Table 30. MRI-Safe Neurostimulation System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global MRI-Safe Neurostimulation System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global MRI-Safe Neurostimulation System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global MRI-Safe Neurostimulation System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America MRI-Safe Neurostimulation System Growth Accelerators and Market Barriers
 Table 37. North America MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America MRI-Safe Neurostimulation System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe MRI-Safe Neurostimulation System Growth Accelerators and Market Barriers
 Table 40. Europe MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe MRI-Safe Neurostimulation System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific MRI-Safe Neurostimulation System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific MRI-Safe Neurostimulation System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America MRI-Safe Neurostimulation System Investment Opportunities and Key Challenges
 Table 47. Central and South America MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa MRI-Safe Neurostimulation System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa MRI-Safe Neurostimulation System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Inc. Corporation Information
 Table 51. Medtronic Inc. Description and Major Businesses
 Table 52. Medtronic Inc. Product Models, Descriptions and Specifications
 Table 53. Medtronic Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Inc. Sales Value Proportion by Product in 2024
 Table 55. Medtronic Inc. Sales Value Proportion by Application in 2024
 Table 56. Medtronic Inc. Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Inc. MRI-Safe Neurostimulation System SWOT Analysis
 Table 58. Medtronic Inc. Recent Developments
 Table 59. Cyberonics, lnc. Corporation Information
 Table 60. Cyberonics, lnc. Description and Major Businesses
 Table 61. Cyberonics, lnc. Product Models, Descriptions and Specifications
 Table 62. Cyberonics, lnc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Cyberonics, lnc. Sales Value Proportion by Product in 2024
 Table 64. Cyberonics, lnc. Sales Value Proportion by Application in 2024
 Table 65. Cyberonics, lnc. Sales Value Proportion by Geographic Area in 2024
 Table 66. Cyberonics, lnc. MRI-Safe Neurostimulation System SWOT Analysis
 Table 67. Cyberonics, lnc. Recent Developments
 Table 68. AADCO Medical Inc. Corporation Information
 Table 69. AADCO Medical Inc. Description and Major Businesses
 Table 70. AADCO Medical Inc. Product Models, Descriptions and Specifications
 Table 71. AADCO Medical Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. AADCO Medical Inc. Sales Value Proportion by Product in 2024
 Table 73. AADCO Medical Inc. Sales Value Proportion by Application in 2024
 Table 74. AADCO Medical Inc. Sales Value Proportion by Geographic Area in 2024
 Table 75. AADCO Medical Inc. MRI-Safe Neurostimulation System SWOT Analysis
 Table 76. AADCO Medical Inc. Recent Developments
 Table 77. Boston Scientific Corporation Information
 Table 78. Boston Scientific Description and Major Businesses
 Table 79. Boston Scientific Product Models, Descriptions and Specifications
 Table 80. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Boston Scientific Sales Value Proportion by Product in 2024
 Table 82. Boston Scientific Sales Value Proportion by Application in 2024
 Table 83. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 84. Boston Scientific MRI-Safe Neurostimulation System SWOT Analysis
 Table 85. Boston Scientific Recent Developments
 Table 86. Sorin Corporation Information
 Table 87. Sorin Description and Major Businesses
 Table 88. Sorin Product Models, Descriptions and Specifications
 Table 89. Sorin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Sorin Sales Value Proportion by Product in 2024
 Table 91. Sorin Sales Value Proportion by Application in 2024
 Table 92. Sorin Sales Value Proportion by Geographic Area in 2024
 Table 93. Sorin MRI-Safe Neurostimulation System SWOT Analysis
 Table 94. Sorin Recent Developments
 Table 95. St. Jude Medical Corporation Information
 Table 96. St. Jude Medical Description and Major Businesses
 Table 97. St. Jude Medical Product Models, Descriptions and Specifications
 Table 98. St. Jude Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. St. Jude Medical Recent Developments
 Table 100. Biotronik Corporation Information
 Table 101. Biotronik Description and Major Businesses
 Table 102. Biotronik Product Models, Descriptions and Specifications
 Table 103. Biotronik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Biotronik Recent Developments
 Table 105. Codman & Shurtleff's Corporation Information
 Table 106. Codman & Shurtleff's Description and Major Businesses
 Table 107. Codman & Shurtleff's Product Models, Descriptions and Specifications
 Table 108. Codman & Shurtleff's Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Codman & Shurtleff's Recent Developments
 Table 110. Nevro Corporation Corporation Information
 Table 111. Nevro Corporation Description and Major Businesses
 Table 112. Nevro Corporation Product Models, Descriptions and Specifications
 Table 113. Nevro Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Nevro Corporation Recent Developments
 Table 115. Boston Scientific Corporation Corporation Information
 Table 116. Boston Scientific Corporation Description and Major Businesses
 Table 117. Boston Scientific Corporation Product Models, Descriptions and Specifications
 Table 118. Boston Scientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Boston Scientific Corporation Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. MRI-Safe Neurostimulation System Product Picture
 Figure 2. Global MRI-Safe Neurostimulation System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Implantable Product Picture
 Figure 4. Transcutaneous Product Picture
 Figure 5. Global MRI-Safe Neurostimulation System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospitals & Clinics
 Figure 7. Diagnostic Labs and Centers
 Figure 8. Ambulatory Surgical Centers
 Figure 9. Research Laboratories
 Figure 10. MRI-Safe Neurostimulation System Report Years Considered
 Figure 11. Global MRI-Safe Neurostimulation System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 13. Global MRI-Safe Neurostimulation System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global MRI-Safe Neurostimulation System Revenue Market Share by Region (2020-2031)
 Figure 15. Global MRI-Safe Neurostimulation System Sales (2020-2031) & (K Units)
 Figure 16. Global MRI-Safe Neurostimulation System Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global MRI-Safe Neurostimulation System Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers MRI-Safe Neurostimulation System Sales Volume Market Share in 2024
 Figure 19. Global MRI-Safe Neurostimulation System Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Implantable Revenue Market Share by Manufacturer in 2024
 Figure 22. Transcutaneous Revenue Market Share by Manufacturer in 2024
 Figure 23. Global MRI-Safe Neurostimulation System Sales Market Share by Type (2020-2031)
 Figure 24. Global MRI-Safe Neurostimulation System Revenue Market Share by Type (2020-2031)
 Figure 25. Global MRI-Safe Neurostimulation System Sales Market Share by Application (2020-2031)
 Figure 26. Global MRI-Safe Neurostimulation System Revenue Market Share by Application (2020-2031)
 Figure 27. North America MRI-Safe Neurostimulation System Sales YoY (2020-2031) & (K Units)
 Figure 28. North America MRI-Safe Neurostimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers MRI-Safe Neurostimulation System Sales Revenue (US$ Million) in 2024
 Figure 30. North America MRI-Safe Neurostimulation System Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America MRI-Safe Neurostimulation System Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe MRI-Safe Neurostimulation System Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe MRI-Safe Neurostimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers MRI-Safe Neurostimulation System Sales Revenue (US$ Million) in 2024
 Figure 40. Europe MRI-Safe Neurostimulation System Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe MRI-Safe Neurostimulation System Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 45. France MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific MRI-Safe Neurostimulation System Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific MRI-Safe Neurostimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers MRI-Safe Neurostimulation System Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific MRI-Safe Neurostimulation System Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific MRI-Safe Neurostimulation System Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 60. India MRI-Safe Neurostimulation System Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America MRI-Safe Neurostimulation System Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America MRI-Safe Neurostimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers MRI-Safe Neurostimulation System Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America MRI-Safe Neurostimulation System Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America MRI-Safe Neurostimulation System Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa MRI-Safe Neurostimulation System Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa MRI-Safe Neurostimulation System Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers MRI-Safe Neurostimulation System Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa MRI-Safe Neurostimulation System Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa MRI-Safe Neurostimulation System Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa MRI-Safe Neurostimulation System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa MRI-Safe Neurostimulation System Revenue (2020-2025) & (US$ Million)
 Figure 81. MRI-Safe Neurostimulation System Industry Chain Mapping
 Figure 82. Regional MRI-Safe Neurostimulation System Manufacturing Base Distribution (%)
 Figure 83. Global MRI-Safe Neurostimulation System Production Market Share by Region (2020-2031)
 Figure 84. MRI-Safe Neurostimulation System Production Process
 Figure 85. Regional MRI-Safe Neurostimulation System Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Implantable Neurostimulation System Market Research Report 2024
Implantable Neurostimulation Devices Market
Global Implantable Neurostimulators Market Research Report 2024
Global Neurostimulation Systems Market Research Report 2024
Low Frequency Sine Wave Neurostimulation Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Internal Neurostimulation Devices Market Research Report 2024
Global MRI Safe Defibrillator Market Insights Forecast to 2030
Global MRI Safe Implantable Device Market Research Report 2024
Global Neurostimulation and Neuromodulation Device Market Research Report 2024
Global MRI Equipment Market Research Report 2025
Global Implantable Neuromodulation System Market Research Report 2024
Global Neurostimulator Medical Device Market Research Report 2024
MRI Safe Cardiac Resynchronization Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Neuromodulation Device Market Research Report 2025
Global Spinal Cord Stimulation System Market Research Report 2024
Global Transcranial Magnetic Stimulation Treatment Devices Market Research Report 2025
Global Peripheral Neurostimulator System Market Research Report 2025
Global Children s Magnetic Field Stimulator Market Research Report 2024
MRI Magnetic Resonance Imaging Machines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Invasive Transcranial Stimulation System Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions